Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody

Ann Rheum Dis. 2006 Dec;65(12):1667-9. doi: 10.1136/ard.2006.054197.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Chronic Disease
  • Epstein-Barr Virus Infections / chemically induced*
  • Fatal Outcome
  • Female
  • Humans
  • Middle Aged
  • Opportunistic Infections / chemically induced
  • Receptors, Interleukin-6 / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Receptors, Interleukin-6
  • tocilizumab